货运代理商需凭专业能力做好医药物流
Forwarders need to be specialists to make pharma work
Pharma.Aero秘书长Frank van Gelder表示,中小型货运代理商进入医药物流应避开与跨国企业正面竞争,聚焦临床试验、时效性医疗运输、先进疗法及专业区域通道等领域。运营商需具备GDP合规、合格人员、经验证的流程和温控能力,不能仅凭认证或利润预期进入市场。可靠的系统、专业知识、团队应变能力与合作伙伴关系,是中小企业应对中断并建立竞争力的基础。
13 November 2026
SME forwarders looking to enter pharmaceutical logistics should avoid competing directly with multinationals and instead focus on building specialist capabilities, says Pharma.Aero secretary general Frank van Gelder.
Rising demand from clinical trials and time-critical healthcare shipments, together with the emergence of advanced therapies, is creating opportunities for SMEs, but Mr van Gelder said operators must demonstrate the requisite expertise, systems quality and dependability.
He told The Loadstar: “SME forwarders should become indispensable specialists. The opportunities are in clinical trials, time-critical healthcare, advanced therapies, specialised regional corridors and high-touch services around research centres and hospitals.
“An SME can combine local knowledge, quick decision-making and trusted international partners. Emerging connections with Chinese and Indian innovation ecosystems can create further possibilities, provided operators build real expertise rather than simply market a new lane.”
But he warned forwarders off entering the pharma market simply because of the prospect of attractive margins. GDP compliance, qualified personnel, validated procedures, and temperature-control competence were needed to form the foundations of any operation.
Going further, he noted certification alone was not demonstrative of an understanding of the requirements of different pharmaceutical products, with conventional medicines, clinical trial shipments, and personalised therapies presenting a fundamentally divergent set of challenges.
Mr van Gelder added: “Agility without discipline is not resilience, it is risk. The winning combination is systems, specialist knowledge, human adaptability, and trusted partnerships. Collaboration is essential because no one company controls the full patient-critical chain.
“The future is not necessarily about who owns the biggest network, it is about who can orchestrate the most reliable one. Do not compete on price alone. Compete on expertise, reliability, flexibility, and trust.”
This, he added, included an ability to respond to disruption, which offered SMEs a way to distinguish themselves. Mr van Gelder argued that experienced and empowered teams could sometimes adapt faster than larger organisations with slower governance structures.
Workforce resilience, he said, meant giving employees the confidence and authority to raise concerns and act when contingency plans no longer worked.
“Resilience is not created by a contingency plan. It is created by people who can act when that plan no longer works,”
来源:The Loadstar · theloadstar.com